Radius Health, Inc.[RDUS] stock saw a move by 1.46% on Thursday, touching 1.3 million. Based on the recent volume, Radius Health, Inc. stock traders appear to be active. The most recent trading volume of RDUS shares recorded 46.19M shares, which represents the daily volume of traded shares. Analysts estimates state that Radius Health, Inc. [RDUS] stock could reach median target price of $38.00.

Radius Health, Inc. [RDUS] stock additionally went up by +2.74% in the period of the 7 days, recording a gain in performance by 24.17% in the last 30 days. The yearly more of RDUS stock is set at 51.65% by far, with shares price recording returns by 30.90% in the latest quarter. Over the past six months, RDUS shares showcased 52.62% increase. RDUS saw -2.06% change opposing the low price in the last 12 months, also recording 122.55% compared to high within the same period of time.

Radius Health, Inc. [NASDAQ:RDUS]: Analyst Rating and Earnings

Its stock price has been found in the range of 12.81 to 29.11. This is compared to its latest closing price of $28.10.

Keep looking out for the next-scheduled quarterly financial results that this company is expected to put out, which is slated to occur on Thu 7 Nov (In 56 Days).

Fundamental Analysis of Radius Health, Inc. [RDUS]

Now let’s turn to look at profitability: with a current Operating Margin for Radius Health, Inc. [RDUS] sitting at -205.63 and its Gross Margin at +90.47.

This company’s Return on Total Capital is -62.94, and its Return on Invested Capital has reached -84.90%. Its Return on Equity is -146.26, and its Return on Assets is -59.13. These metrics suggest that this Radius Health, Inc. does a poor job of managing its assets, and likely won’t be able to provide successful business outcomes for its investors in the near term.

Turning to investigate this organization’s capital structure, Radius Health, Inc. [RDUS] has generated a Total Debt to Total Equity ratio of 296.55. Similarly, its Total Debt to Total Capital is 74.78, while its Total Debt to Total Assets stands at 62.66. Looking toward the future, this publicly-traded company’s Long-Term Debt to Equity is -8.89, and its Long-Term Debt to Total Capital is 296.55.

What about valuation? This company’s Enterprise Value to EBITDA is -6.08. The Enterprise Value to Sales for this firm is now 9.20, and its Total Debt to Enterprise Value stands at 0.26. Radius Health, Inc. [RDUS] has a Price to Book Ratio of 12.39.

Shifting the focus to workforce efficiency, Radius Health, Inc. [RDUS] earns $249,344 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 9.36 and its Total Asset Turnover is 0.27. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 5.79 and its Current Ratio is 5.92. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.

Radius Health, Inc. [RDUS] has 46.19M shares outstanding, amounting to a total market cap of $1.32B. Its stock price has been found in the range of 12.81 to 29.11. At its current price, it has moved down by -2.06% from its 52-week high, and it has moved up 122.55% from its 52-week low.

This stock’s Beta value is currently 0.79, which indicates that it is 4.45% more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 72.46. This RSI suggests that Radius Health, Inc. is currently Overbought.

Conclusion: Is Radius Health, Inc. [RDUS] a Reliable Buy?

Shares of Radius Health, Inc. [RDUS], overall, appear to be a solid investment option, with Wall Street analysts expecting its price to rise considerably in the next 12 months. This company generates high value from the labor resources and other capital it has available, and while it has heavy Long-Term Debt to Equity, the majority of the metrics point to this investment being highly attractive.